Target
RCG37580
Ligand
BDBM50030790
Substrate
n/a
Meas. Tech.
ChEMBL_1438499 (CHEMBL3384903)
EC50
12±n/a nM
Citation
 Peukert, SHughes, RNunez, JHe, GYan, ZJain, RLlamas, LLuchansky, SCarlson, ALiang, GKunjathoor, VPietropaolo, MShapiro, JCastellana, AWu, XBose, A Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists. ACS Med Chem Lett 5:1114-8 (2014) [PubMed]  Article 
Target
Name:
RCG37580
Synonyms:
Ensembl:ENSRNOP00000036196 | G protein-coupled receptor 39-1b | Gpr39 | Protein Gpr39 | RCG37580
Type:
PROTEIN
Mol. Mass.:
33217.74
Organism:
Rattus norvegicus
Description:
ChEMBL_107978
Residue:
298
Sequence:
MASSSGSSNICSRVIDHSHVPEFEVATWIKITLTLVYLIVFVVGILGNSVTIRVTQVLQKKGYLQKEVTDHMISLACSDILVFLIGMPMEFYSIIWNPLTTPSYALSCKLHTFLFETCSYATLLHVLTLSFERYIAICHPFRYKDVSGPCQVKLLIGFVWVTSALVALPLLFAMGIEYPLANVPTHKGLNCNLSRTRHHDHPGDSNMSICTNLSSRWEVFQSSIFGAFAVYLVVLVSVAFMCWNMMKVLMKSKRGTLAGTGPQLQLRKSESEESRTARRQTIIFLSESGSRGILGPLA
  
Inhibitor
Name:
BDBM50030790
Synonyms:
CHEMBL3342357
Type:
Small organic molecule
Emp. Form.:
C26H31FN6O2S
Mol. Mass.:
510.627
SMILES:
Fc1cccc(c1)S(=O)(=O)NC[C@H]1CC[C@H](CNc2nc(NC3CC3)cc(n2)-c2ccccn2)CC1 |r,wU:12.12,wD:15.16,(2.07,-15.15,;3.4,-14.39,;3.41,-12.84,;4.74,-12.07,;6.07,-12.85,;6.06,-14.39,;4.73,-15.15,;7.38,-15.16,;8.14,-16.49,;6.61,-16.48,;8.72,-14.4,;10.05,-15.18,;11.39,-14.41,;11.4,-12.87,;12.73,-12.11,;14.06,-12.88,;15.4,-12.11,;16.73,-12.89,;18.06,-12.12,;19.4,-12.89,;20.74,-12.11,;22.07,-12.88,;23.4,-12.1,;24.94,-12.09,;24.16,-10.76,;20.73,-10.57,;19.4,-9.81,;18.06,-10.58,;19.4,-8.27,;18.06,-7.5,;18.07,-5.96,;19.39,-5.19,;20.73,-5.95,;20.74,-7.5,;14.07,-14.42,;12.72,-15.19,)|
Structure:
Search PDB for entries with ligand similarity: